INCR Intercure Ltd. - ordinary shares

NASDAQ · Pharmaceuticals
$0.99
Price · Aug 17, 2026

INCR Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range

Price
$0.99
Market Cap
P/E (TTM)
EPS (TTM)
Revenue (TTM)
Div Yield
ROE
Debt/Equity
52W Range
$1 – $2

INCR Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view

10-Year Performance Revenue, net income, margins and EPS trends

Revenue & Net Income
EPS
Free Cash Flow
Margins

Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?

Metric
5Y trend
INCR
Peer Median

Profitability Gross, operating and net margins; ROE, ROA, ROIC

Metric
5Y trend
INCR
Peer Median

Financial Health Debt, liquidity, solvency — balance sheet strength

Metric
5Y trend
INCR
Peer Median

Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR

Metric
5Y trend
INCR
Peer Median

Per Share Metrics EPS, book value per share, cash flow per share, dividend per share

Metric
5Y trend
INCR
Peer Median

Capital Efficiency Asset turnover, inventory turnover, receivables turnover

Metric
5Y trend
INCR
Peer Median

INCR Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside

BUY 7 analysts
  • Strong Buy 2 28.6%
  • Buy 4 57.1%
  • Hold 1 14.3%
  • Sell 0 0.0%
  • Strong Sell 0 0.0%

Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date

Avg Surprise
-0.02%
Period EPS Actual EPS Est Surprise
June 30, 2023 $0.10 $0.08 0.02%
March 31, 2023 $0.01 $0.04 -0.04%
Dec. 31, 2022 $0.19 $0.18 0.00%
Sept. 30, 2022 $0.16 $0.26 -0.10%
March 31, 2022 $0.19 $0.18 0.00%

Peer comparison (GICS sub-industry) Key metrics vs sector peers

Ticker Market Cap P/E Rev YoY Net Margin ROE Gross Margin
INCR
SLGL
MDWD
PYPD

My Metrics Your personal watchlist — selected rows from Full Fundamentals

📊

Pick the metrics that matter to you — click the ➕ next to any row in Full Fundamentals above.

Your selection is saved and follows you across all tickers.

Institutional owners (13F) 17 filers · $741K total · As of June 30, 2026

Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.

Institutional activity — Q2 2026 vs prior quarter
New positions Exited positions Increased Decreased Net shares change
2 (+1 vs prior Q) 1 (-3 vs prior Q) 2 (+1 vs prior Q) 4 (+2 vs prior Q) +9K

Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.

Institution Value Shares % of tracked 13F Type
HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND $325,125 212,500 43.89% Shares
CITADEL ADVISORS LLC $118,704 107,913 16.02% Shares
MOORE CAPITAL MANAGEMENT, LP $107,000 97,273 14.44% Shares
RENAISSANCE TECHNOLOGIES LLC $63,580 57,800 8.58% Shares
Revisor Wealth Management LLC $45,482 41,348 6.14% Shares
GEODE CAPITAL MANAGEMENT, LLC $22,392 20,357 3.02% Shares
BlackRock, Inc. $14,925 13,568 2.01% Shares
Atria Investments, Inc $13,153 11,957 1.78% Shares
Quent Capital, LLC $11,353 10,321 1.53% Shares
Quent Long Short Global Small Cap Fund, LP $9,392 10,321 1.27% Shares
MORGAN STANLEY $4,400 4,000 0.59% Shares
PenderFund Capital Management Ltd. $2,175 1,977 0.29% Shares
UBS Group AG $1,466 1,333 0.20% Shares
Financial Network Wealth Advisors LLC $1,100 1,000 0.15% Shares
NATIONAL BANK OF CANADA /FI/ $517 508 0.07% Shares
Virtu Financial LLC $25 22,485 0.00% Shares
ROYAL BANK OF CANADA $0 196 0.00% Shares

Activists & 5%+ owners 1 position

Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.

Filer Filed Stake Status Purpose Filing
Alexander Rabinovich, D.I.M Investments Ltd. Dec. 9, 2025 29.40% Initial filing SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.